Clarus Therapeutics Holdings, Inc. CRXT
0.05 USD 0.00 (+0.00%)
Sep 6, 2022, 3:59 PM EDT
0.0475 Day range 0.0749
52-week range unavailable
Valuation
P/E -1.0×
FY 2020 5y median -0.5× FY 2021
P/S 4.2×
FY 2020 5y median 2.1× FY 2021
P/B -3.7×
FY 2020 5y median 0.3× FY 2021
P/FCF -1.3×
FY 2020 5y median -0.7× FY 2021
EV/EBITDA -3.0×
FY 2020 5y median -3.3× FY 2021
EV/Sales 5.3×
FY 2020 5y median 2.7× FY 2021
FCF Yield -75.0%
FY 2020 5y median -37.5% FY 2021
Profitability
Gross Margin 80.5%
FY 2020 5y median 40.3% FY 2021
Operating Margin -177.1%
FY 2020 5y median -88.6% FY 2021
Net Margin -404.9%
FY 2020 5y median -202.5% FY 2021
ROE 355.0%
FY 2020 5y median 177.5% FY 2021
ROIC -88.6%
FY 2020 5y median -44.3% FY 2021
ROA -109.3%
FY 2020 5y median -54.6% FY 2021
Growth (YoY)
Revenue 0.0%
FY 2020 FY 2021
Operating Income 47.6%
FY 2020 FY 2021
EPS (diluted) 0.0%
FY 2020 FY 2021
Free Cash Flow 0.0%
FY 2020 FY 2021
Financial Health
Current Ratio 0.8×
FY 2020 5y median 1.4× FY 2021
Quick Ratio 0.6×
FY 2020 5y median 1.3× FY 2021
Debt / Equity -2.7×
FY 2020 5y median -1.3× FY 2021
Net Debt / EBITDA -0.6×
FY 2020 5y median -0.3× FY 2021
Interest Coverage -1.6×
FY 2020 5y median -0.8× FY 2021
Dividends
Dividend Yield 13.3%
FY 2020 5y median 6.6% FY 2021
Payout Ratio -13.7%
FY 2020 5y median -6.8% FY 2021
Annual · latest fiscal year ends 2021-12-31